Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000902493) titled 'Safety and tolerability of plasma-activated water wound rinse for foot ulcers' on Aug. 20.
Study Type: Interventional
Study Design:
Purpose: Prevention
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Safety/efficacy
Primary Sponsor: Central Adelaide Local Health Network
Condition:
diabetes-related foot ulcer
diabetes-related foot ulcer
Infection - Studies of infection and infectious agents
Metabolic and Endocrine - Diabetes
Intervention:
Participants will receive 20mL plasma-activated water as a rinse, applied to gauze as a temporary dressin...